G medical innovations holdings ltd. announces receipt of nasdaq minimum bid price notification

Rehovot, israel, may 19, 2023 (globe newswire) --  g medical innovations holdings ltd. (nasdaq: gmvd) (the “company”), a telehealth, medical device, and remote patient monitoring company, announced today that on may 15, 2023 it received a written notice (the “notice”) from nasdaq stock market llc, indicating that the company is not in compliance with the minimum bid price requirement for continued listing set forth in nasdaq listing rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. under nasdaq listing rule 5810(c)(3)(a), the company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. the notice has no immediate effect on the company's nasdaq listing or the trading of its ordinary shares, and during the grace period, as may be extended, the company's ordinary shares will continue to trade on the nasdaq capital market under the symbol “gmvd”, subject to the company meeting the conditions set forth by the nasdaq hearings panel (the “panel”) related to nasdaq's shareholders equity requirement pursuant to the letter received from the panel on may 11, 2023 as described by the company on its press release dated may 15, 2023.
GMVD Ratings Summary
GMVD Quant Ranking